Protein Frontiers ApS

Private limited companyCVR 43132709GentofteActive

Protein Frontiers ApS is a private limited company, based in Gentofte, active in research and experimental development on natural sciences and engineering, founded in 2022. The company went from a profit in 2024 to a loss of DKK 149k in 2025. 7 people are registered in the company's management and ownership.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 513k−33.2% vs. 2024
Net profit−DKK 149k−124.8% vs. 2024
EquityDKK 1.2m+11% vs. 2024
Employees4latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 33% (2024 → 2025), to DKK 513k.
  • Net profit went from a profit of DKK 601k to a loss of DKK 149k (2024 → 2025).
  • Equity rose 11% (2024 → 2025), to DKK 1.2m.

Employees

  • 2 more employees than a year earlier: 4 (07/2026) against 2 (07/2025).

Management and owners, last 24 months

  • New in management: Hans Peder Morten Laursen Meldgaard (board member, 21/11/2025).
  • New owners registered: Viridis Futurum ApS (19/09/2025).

Registrations, last 24 months

  • 10/09/2025: Share capital changed from 100,000 DKK to 125,000 DKK
  • 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2022–2025 · amounts in DKK thousand

Equity and net profit

−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2m2022202320242025
EquityNet profit
Financial figures for Protein Frontiers ApS
2022202320242025Change
Revenuenot statednot statednot statednot stated–
Gross profit−180610768513−33.2%
Operating profit (EBIT)–––−217–
Profit before tax−180606766−217−128.3%
Net profit−180546601−149−124.8%
Total assets2261,3111,0992,160+96.6%
Equity−804651,0671,184+11%
Liabilities30784633977+2,900.3%
Cash and cash equivalents9539454945+1,643.9%
Average number of employees––01–

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 200kDKK 0DKK 200kDKK 400kDKK 600kDKK 800k2022202320242025
Gross profitMedian, the industry (431 companies)

Annual reports

4 financial years
Annual reports for Protein Frontiers ApS
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202512/06/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202419/06/2025The companyPDFXBRL
202301/01/2023 – 31/12/202328/06/2024The companyPDFXBRL
202210/03/2022 – 31/12/202230/06/2023The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123456709/2210/2211/2212/2201/2302/2303/2304/2305/2306/2312/2305/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

431 companies in the database

Comparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.

Gross profitDKK 513kNo. 216 of 421
Better than 49% of the companies in the industry
EquityDKK 1.2mNo. 237 of 431
Better than 45% of the companies in the industry
Number of employees4No. 351 of 431
Better than 19% of the companies in the industry

Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.

DKK 100kDKK 2.5mDKK 63.4mDKK 1.6bnDKK 13.7bnHere
Distribution of gross profit for 250 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 54,020of 69,742
Better than 23%
No. 31,450of 69,964
Better than 55%
Same industry and fewer than 20 employees329 companies in the comparison
No. 142of 323
Better than 56%
No. 149of 329
Better than 55%
Companies that are founded within the last five years16,662 companies in the comparison
No. 11,920of 16,614
Better than 28%
No. 3,520of 16,661
Better than 79%
All companies of type ApS66,508 companies in the comparison
No. 51,982of 66,379
Better than 22%
No. 27,381of 66,505
Better than 59%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Research and experimental development on natural sciences and engineering
Gross profit
  1. Protein Frontiers ApSDKK 513k
  2. Carlsberg A/SDKK 40.2bn
  3. Zealand Pharma A/SDKK 9.2bn
Net profit
  1. Protein Frontiers ApS−DKK 149k
  2. Carlsberg A/SDKK 7bn
  3. Zealand Pharma A/SDKK 6.5bn
Equity
  1. Protein Frontiers ApSDKK 1.2m
  2. Carlsberg A/SDKK 30.7bn
  3. Zealand Pharma A/SDKK 14.8bn
Employees
  1. Protein Frontiers ApS4
  2. Carlsberg A/S107
  3. Zealand Pharma A/S569

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • MPLU Biorefining Aps20%
  • NKS Investment ApS20%
  • H Sønksen Holding ApS20%
  • Solheim22 Holding ApS20%
  • Viridis Futurum ApS20%
Protein Frontiers ApS

Management

7 active registrations

Executive management

Executive management at Protein Frontiers ApS
NameRoleAppointed
Henrik SønksenDirector10/03/2022

Board of directors

Board of directors at Protein Frontiers ApS
NameRoleAppointed
Henrik SønksenBoard member10/03/2022
Lasse Solheim HansenBoard member10/03/2022
Niels Kristian SørensenChair of the board10/03/2022
Peter LübeckDeputy chair10/03/2022
Mette LübeckBoard member10/03/2022
Hans Peder Morten Laursen MeldgaardBoard member21/11/2025
Founders
MPLU Biorefining Aps, NKS Investment ApS, H Sønksen Holding ApS, Solheim22 Holding ApS

Signing rule: Selskabet tegnes af den samlede direktion sammen med bestyrelsesformanden.

Address and production units

1 active production units

C L Ibsens Vej 7
2820 Gentofte

Gentofte Municipality · Postcode 2820

Other companies at the address (1)

  • Pulito ApSRetail sale of kitchen equipment and tableware
Production units
Production unitAddressEmployeesP number
Protein Frontiers ApSC L Ibsens Vej 7, st, 2820 Gentofte41028092098

Purpose

Selskabets formål er at drive virksomhed med forskning, udvikling og kommercialisering af aktiviteter til produktion af rekombinant cellulære proteiner til fødevarer på medier af sidestrømme. Herunder at udvikle teknikker til industriel opskalering af disse proteiner og afledte produkter heraf samt indgåelse af global eksklusiv aftaler til udnyttelse af patenter.

The purpose is quoted from the register in Danish.

Changes year by year

21 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20255 changesmanagement 1 · ownership 1 · capital 1 · accounts 1 · industry 1
  • Hans Peder Morten Laursen Meldgaard appointed board member
  • Viridis Futurum ApS registered as owner (20%)
  • Share capital changed from 100,000 DKK to 125,000 DKK
  • Annual report for 2024 published
  • Industry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesaccounts 1 · address 1
  • Annual report for 2023 published
  • Moved to C L Ibsens Vej 7, st, 2820 Gentofte
20232 changesaccounts 1 · address 1
  • Annual report for 2022 published
  • Moved to C L Ibsens Vej 7, st, 2820 Gentofte
202211 changesfounded 1 · management 6 · ownership 4
  • Registered as Protein Frontiers ApS
  • Henrik Sønksen appointed board member
  • Lasse Solheim Hansen appointed board member
  • Henrik Sønksen appointed director
  • Peter Lübeck appointed deputy chair
  • Mette Lübeck appointed board member
  • Niels Kristian Sørensen appointed chair of the board
  • MPLU Biorefining Aps registered as owner (20%)
  • NKS Investment ApS registered as owner (20%)
  • H Sønksen Holding ApS registered as owner (20%)
  • Solheim22 Holding ApS registered as owner (20%)

Related companies

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction